Cure My Disease

Don't miss your cure!

 Log in / Sign up

New hope for hepatitis b: experimental drug shows promise in mid-stage trial

NCT ID NCT04412863

Completed Disease control Sponsor: Vir Biotechnology, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested an experimental drug called VIR-2218 in 84 adults with chronic hepatitis B. Some participants received VIR-2218 alone, and others got it combined with pegylated interferon. The main goals were to check safety and how well the drug works against the virus. The study is complete, and results will help decide if further testing is needed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic hepatitis B virus infection hepatitis hepatitis B virus infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CHRONIC HEPATITIS B

Contacts and locations

Locations

  • Investigative Site

    Birtinya, Queensland, 4575, Australia

  • Investigative Site

    Fitzroy, Victoria, 3168, Australia

  • Investigative Site

    Batu Caves, 68100, Malaysia

  • Investigative Site

    Kajang, 43000, Malaysia

  • Investigative Site

    Kuala Lumpur, 59100, Malaysia

  • Investigative Site

    Kuantan, 25100, Malaysia

  • Investigative Site

    Auckland, 1010, New Zealand

  • Investigative Site

    Auckland, 2025, New Zealand

  • Investigative Site

    Busan, 49241, South Korea

  • Investigative Site

    Chuncheon, 24253, South Korea

  • Investigative Site

    Daegu, 41944, South Korea

  • Investigative Site

    Seoul, 03080, South Korea

  • Investigative Site

    Seoul, 05505, South Korea

  • Investigative Site

    Yangsan, 50612, South Korea

  • Investigative Site

    Bangkok, 10330, Thailand

  • Investigative Site

    Bangkok, 10400, Thailand

  • Investigative Site

    Bangkok, 10700, Thailand

  • Investigative Site

    Chiang Mai, 50200, Thailand

  • Investigative Site

    Hat Yai, 90110, Thailand

  • Investigative Site

    Khlong Luang, 12120, Thailand

  • Investigative Site

    Khon Kaen, 40002, Thailand

  • Investigative site

    Hong Kong, Hong Kong

More trials for these conditions

Other studies related to the condition(s) this trial covers.